Table 1 Comparison of embryonic development potential after MI and MII ooplasmic transfer (OT) in mammalian sample
From: Ooplasmic transfer in human oocytes: efficacy and concerns in assisted reproduction
Supplier information | Survival information | Pregnancy information | Explanation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Species | D | R | OT (%) | Fertilized (%) | 2-cell (%) | 4-cell (%) | 6-cell (%) | 8-cell (%) | Blastocyst (%) | ET (%) | pregnancy | Birth | |
Monkey [4] | MII | MI | 42 | 23 (54.8%) | – | – | – | – | – | – | 4 (9.5%) | 3 (7.1%) | – |
Sham MI | 43 | 26 (60.5%) | – | – | – | – | – | – | 0 | 0 | – | ||
Control MI | 37 | 30 (81%) | – | – | – | – | – | – | 0 | 0 | – | ||
MII | MII | 22 | 22 (100%) | – | – | – | – | – | – | 4 (18%) | 4 (18%) | – | |
Sham MII | 18 | 18 (100%) | – | – | – | – | – | – | 3 (16.7%) | 3 (16.7%) | – | ||
Control MII | 24 | 24 (100%) | – | – | – | – | – | – | 6 (25%) | 4 (16%) | |||
Human [1] | MII | MII | 14(100) | 9 (64.3%) | 8 (57.1%) | 8 (57.1%) | 8 (57.1%) | 8 (57.1%) | 4 (28.6%) | 4 (28.6%) | 1 (7.1%) | 1 (7.1%) | amniocyte nDNA and mtDNA fingerprinting |
Human [16] | MII | MII | 22 fused | 15 (68.2%) | – | – | – | 10 (46.4%) | – | 3 (13.6%) | 0 | 0 | amniocyte nDNA and mtDNA fingerprinting |
MII | MII | 48 | 38 (79.17%) | – | – | – | 8(16.7) | – | 5 (10.4%) | 3 (6.3%) | 1 (2.1%) | amniocyte nDNA and mtDNA fingerprinting | |
Control MII | 17 | 9 (52.9%) | – | – | – | 0 | – | – | – | – | – | ||
Human [18] | Cryo_MII | MII | 37 | 26 (70.3%) | – | – | – | – | – | 17 (45.9%) | 2 | 2 (5%) | – |
Human [19] | 3PN | MII | 62 | 44 (80%) | 39 (63%) | – | 39 (63%) | – | – | 39 (63%) | 4 (6.4%) | 4 | amniocentesis and karyotyping |
Human [20] | MII | MII | 26 | – | – | – | – | – | – | – | – | 2 (7.7%) | Confocal microscopy and mtDNA fingerprinting |
Human [21] | MII | MII | 8 | 6 (75%) | 6 (75%) | 5 (62.5%) | 4 (50%) | 2 (25%) | – | 4 (50%) | 2 (25%) | 2 (25%) | – |
MII Control | 4 | 3 (75%) | 3 (75%) | 1 (25%) | – | – | – | – | – | – | – | ||